Skip to main content

Dag Årsland Group

Translational Geriatric Neuropsychiatry

Picture of Dag Aarslands group members

The group was established in 2011, and our main focus is to study cognition and depression and other neuropsychiatric disturbances in elderly people with brain diseases, with a particular focus on the non-Alzheimer dementias such as Parkinsons disease and dementia with Lewy bodies.

Research focus

In addition to studying clinical phenotypes and longitudinal course, we aim at exploring underlying mechanisms and developing novel biomarker and treatment targets. The group is highly inter-disciplinary, and collaborates with the many excellent groups at the division and with Per Svenningssons group at Department of Neuroscience, as well as Elisabeth Londos group in Malmö. In addition, we have international collaborators including professor Tormod Fladby, University of Oslo,and Centre for Age-Related Research at Stavanger University Hospital in Norway, and professor Clive Ballard and his team at Wolfson Centre for Age-Related Diseases, Kings College London.

Group members

Group members

Dag Aarsland Professor
Erika Bereczki Postdoc
Daniela Enache PhD student
Alekandra Lebedeva PhD student
Walid Tajeddinn PhD student
Alexandra Bernadotte PhD student
Frida Göthe PhD student


Depression in Parkinson disease--epidemiology, mechanisms and management.
Aarsland D, Påhlhagen S, Ballard C, Ehrt U, Svenningsson P
Nat Rev Neurol 2011 Dec;8(1):35-47

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial.
Husebo B, Ballard C, Sandvik R, Nilsen O, Aarsland D
BMJ 2011 Jul;343():d4065

Depression in dementia: epidemiology, mechanisms, and treatment.
Enache D, Winblad B, Aarsland D
Curr Opin Psychiatry 2011 Nov;24(6):461-72

Alzheimer's disease.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E
Lancet 2011 Mar;377(9770):1019-31

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.
Svenningsson P, Westman E, Ballard C, Aarsland D
Lancet Neurol 2012 Aug;11(8):697-707

Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment.
Göthe F, Enache D, Wahlund L, Winblad B, Crisby M, Lökk J, et al
Panminerva Med 2012 Sep;54(3):161-70

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease.
Kramberger M, Jelic V, Kåreholt I, Enache D, Eriksdotter Jönhagen M, Winblad B, et al
Dement Geriatr Cogn Dis Extra 2012 Jan;2(1):48-56

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Hanney M, Prasher V, Williams N, Jones E, Aarsland D, Corbett A, et al
Lancet 2012 Feb;379(9815):528-36

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, et al
Lancet Neurol 2009 Jul;8(7):613-8

Assessment and treatment of pain in people with dementia.
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, et al
Nat Rev Neurol 2012 Apr;8(5):264-74